Onyx Scientific

Onyx Scientific provides end-to-end chemistry solutions for small molecule drug substance development and manufacturing, supporting projects from early discovery through clinical phases to commercial supply. They are recognized for technical expertise in process R&D, solid-state chemistry, analytical services, and GMP/non-GMP API scale-up.

The company does not have its own clinical pipeline or results as it operates as a service provider.

Client testimonials highlight strong technical knowledge and efficient project delivery.

Since joining Ipca Laboratories in 2011, the company has expanded its capabilities with facilities in the UK and US.

In 2021 they added commercial manufacturing capabilities at their UK site.

Their sites are MHRA licensed with regulatory approvals including EMA (Europe), ISO certification, and GMP compliance.

They handle high potent products up to OEB 3 level.

Services include analytical method development/validation, custom synthesis of APIs under cGMP conditions for preclinical through commercial stages.

No proprietary drugs or programs; all work performed on behalf of clients.